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Expression of a-synuclein is increased in the
hippocampus of rats with high levels of innate anxiety
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A genomic region neighboring the a-synuclein gene, on rat chromosome 4, has been
associated with anxiety- and alcohol-related behaviors in different rat strains. In this study, we
have investigated potential molecular and physiological links between a-synuclein and the
behavioral differences observed between Lewis (LEW) and Spontaneously Hypertensive (SHR)
inbred rats, a genetic model of anxiety. As expected, LEW rats appeared more fearful than SHR
rats in three anxiety models: open field, elevated plus maze and light/dark box. Moreover, LEW
rats displayed a higher preference for alcohol and consumed higher quantities of alcohol than
SHR rats. a-Synuclein mRNA and protein concentrations were higher in the hippocampus, but
not the hypothalamus of LEW rats. This result inversely correlated with differences in
dopamine turnover in the hippocampus of LEW and SHR rats, supporting the hypothesis that
a-synuclein is important in the downregulation of dopamine neurotransmission. A novel single
nucleotide polymorphism was identified in the 30-untranslated region (30-UTR) of the a-
synuclein cDNA between these two rat strains. Plasmid constructs based on the LEW 30-UTR
sequence displayed increased expression of a reporter gene in transiently transfected PC12
cells, in accordance with in-vivo findings, suggesting that this nucleotide exchange might
participate in the differential expression of a-synuclein between LEW and SHR rats. These
results are consistent with a novel role for a-synuclein in modulating rat anxiety-like behaviors,
possibly through dopaminergic mechanisms. Since the behavioral and genetic differences
between these two strains are the product of independent evolutionary histories, the
possibility that polymorphisms in the a-synuclein gene may be associated with vulnerability
to anxiety-related disorders in humans requires further investigation.
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Introduction
Anxiety-related disorders constitute a major public
health concern as they are the most prevalent class of
human psychopathologies.
1,2 Measurable psychologi-
cal and behavioral phenotypes associated with anxi-
ety, either in humans or animal models, have been
shown to depend to a large extent on the actions of
multiple genes.
3–9 Nevertheless, the genes and mole-
cular pathways involved remain largely unknown,
and this is an important limitation to the develop-
ment of more efficient therapeutic methods.
Quantitative trait locus (QTL) analysis is a genetic
strategy used to map genomic regions associated with
specific polygenic traits, but it can also reveal genetic
correlations between distinct phenotypes.
10,11
Through the use of an F2 population derived from
two inbred rat strains that differ for several anxiety-
related behaviors, Lewis (LEW) and Spontaneously
Hypertensive rats (SHR),
12,13 a locus on rat chromo-
some 4 was found to affect locomotion in the central
area of an open field (OF),
14 a putative index of
experimental anxiety.
4,15–18 The behavioral effects of
this QTL, named Ofil1, were confirmed and extended
through the use of recombinant lines derived from
LEW and SHR rats,
19,20 suggesting that this genome
region harbors one or more genes influencing anxiety-
related behaviors and alcohol consumption.
Snca is one of the candidate genes that maps to this
large area of rat chromosome 4. It encodes the a-
synuclein protein, which is widely expressed in the
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terminals.
21 a-Synuclein inhibits the enzyme tyrosine
hydroxylase, thereby downregulating the synthesis of
dopamine (DA).
22,23 a-Synuclein is implicated in
neurodegenerative disorders
24 such as Parkinson’s
disease,
25–28 and high levels of a-synuclein mRNA
have been associated with alcoholism in humans
29,30
and alcohol preference in rats.
31 Since anxiety is a
common feature in Parkinson’s patients,
32 and also in
alcoholics,
33,34 a-synuclein may also be important in
anxiety.
The aim of the present study was to test the
potential involvement of a-synuclein in the genetic
control of emotionality- and alcohol-related beha-
viors. To this end, LEW and SHR inbred rats were
compared using (1) three behavioral tests of anxiety/
emotionality; (2) measurement of spontaneous alco-
hol consumption; (3) measurement of expression of
the Snca gene and a-synuclein protein in the rat
brain; (4) measurement of the concentration of DA
and its metabolites in rat brain and (5) analysis of the
DNA sequences of a polymorphic region of Snca,
which have been suggested to regulate its expression.
Finally, we generated an F2 panel to investigate the
cosegregation of the single nucleotide polymorphism
(SNP) identified in the a-synuclein gene with anxiety-
like behaviors and alcohol preference.
Materials and methods
Animals
The colony of inbred SHR rats, originally acquired
from Harvard University (Boston, MA, USA) and
Taconic (Germantown, NY, USA), was obtained from
UNESP (Botucatu, SP, Brazil) and UNICAMP (Campi-
nas, SP, Brazil). The inbred LEW strain, originally
acquired from Harlan Sprague Dawley Inc. (Indiana-
polis, IN, USA), was obtained from UNICAMP
(Campinas, SP, Brazil). The animals arrived in our
laboratory (University of Sao Paulo Medical School,
SP, Brazil) at 6–7 weeks of age. They were left
undisturbed for at least 1 week in standard plastic
cages (five rats per cage) with food and water
available ad libitum under a 12:12 light/dark cycle
(lights on at 0700 hours) and at 22±21C. The rats
used in the alcohol self-administration procedure,
elevated plus maze (EPM) and light/dark box (LDB)
experiments were born, raised and tested in our
second laboratory (Federal University of Santa Catar-
ina, Florianopolis, Brazil), under similar conditions.
Only male rats naive for all experimental procedures
were used in the present study, 22 rats (11 per strain)
were used for the alcohol self-administration experi-
ments, 15 rats (7–8 per strain) were used for the OF
test followed by gene expression assays, 16 rats (8 per
strain) were used for the EPM followed by the LDB, 20
rats (10 per strain) were used for the OF test followed
by HPLC measurements and an additional 20 rats (10
per strain) were used for western blot and immuno-
histochemistry analyses. Finally, 5 LEW female and 5
SHR male rats were intercrossed to produce 12 F1
breeding pairs, which were then mated to produce the
F2 offspring. In total, 73 F2 male rats were tested in an
OF and an alcohol protocol, before being genotyped.
The experiments were in accordance with the local
regulations for the ethical use of animals in research,
which follow the guidelines from the USA National
Research Council.
Open field
The apparatus consisted of a square arena
(100 100cm) surrounded by 40-cm high walls made
of wood covered with white formica. The floor was
divided into 36 equal-sized squares by black lines,
and illumination inside the arena was B80 lux during
the experiments. The rats were isolated in plastic
cages (12 26 15cm) 2h before the tests and kept
without being disturbed. Each rat was placed in the
center of the OF and its behavior was recorded by a
video camera for 5min. The variables analyzed were
number of quadrants entered with the four paws
either in the central (away from the wall), or the
peripheral (adjacent to the wall) quadrants and the
percentage of central quadrants in relation to the total
quadrants (centralþperipheral) crossed. The floor of
the arena was cleaned between rats with a 5%
alcohol:water solution. Recording and cleaning meth-
ods were kept unaltered for the other two behavioral
tests.
Elevated plus maze
The apparatus was made of wood covered with black
formica and had four elevated arms (52cm above the
floor), 50cm long and 10cm wide. Two opposite arms
were enclosed by 40cm high opaque walls and the
other two were open with a small lip (1mm thick and
5mm high). A central platform at the intersection
(10 13.5cm) was under 80 lux of illumination and
gave access to any of the four arms. Each rat was
placed on the central platform facing an open arm,
and the number of entries and the time spent (with all
four paws) inside each type of arm were registered for
5min. The percentage of time in the open arms was
calculated in relation to the total time the animal
spent inside any of the four arms.
Light/dark box
The apparatus was made of wood covered with
formica and consisted of two compartments. The
larger compartment (27 27 27cm) was white, and
the floor was divided into nine squares (9 9cm) by
black lines, and strongly illuminated by a 40W white
bulb. The other smaller compartment (27 18 27cm
high) was black, and the floor was divided into six
squares (9 9cm) by white lines and illuminated by a
40W red bulb. Both white and red bulbs were located
30cm above the floor of the apparatus, thus providing
900 and 25 lux inside each compartment, respec-
tively. The two compartments were separated by a
wall and were connected by a small square opening
(7 7cm). Each rat was placed in the center of the
white compartment and the number of squares
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compartment were registered for 5min. The percen-
tage of time in the white compartment was calculated
in relation to the total time the animal spent with all
four paws inside any of the two compartments.
Alcohol consumption and preference
A standardized testing procedure for alcohol prefer-
ence was used.
35 Briefly, the procedure consisted of
two bottles of either alcohol solution or water that
were available continuously as a free choice to
animals kept alone in plastic cages (21 28 19cm)
with ad libitum access to food. A self-administration
protocol was used for seven successive periods of 2
days for each of the following conditions: (1) 2 days of
free choice between saccharine (7.5mM) and water;
(2) 2 days of free choice between quinine (2 M) and
water; (3) 2 days of forced ethanol (10%) and (4) 8
days of free choice between ethanol (2, 4, 6 and 10%)
and water (2 days for each concentration). The total
consumption of each solution and body weight was
measured every 2 days at 1600 hours by weighing the
bottles, and the positions of the bottles were switched
every day to prevent position bias. The data are
presented in terms of absolute consumption (ml), g of
alcohol per day per kg of body weight, or % of alcohol
preference relative to total fluid intake.
Gene expression by real-time PCR
Another set of animals were decapitated and their
brains were rapidly removed 1 day after the OF test.
The entire hippocampus and hypothalamus were
dissected in a cold Petri dish, snap frozen in liquid
nitrogen and stored at  801C until used. Frozen brain
samples were immersed in TRIzol reagent (Invitrogen,
Carlsbad, CA, USA) and homogenized (Polytron
PT10/35-Brinkmann, Westbury, NY, USA) for 30s
using the maximum speed. Total RNA was isolated
according to the manufacturer’s guidelines. The RNA
was quantified using a spectrophotometer and its
purity was assessed by the OD ratio (260/280nm). The
integrity of RNA was verified on an ethidium
bromide-stained 1% agarose gel, and the fluorescence
intensity ratio of 28S/18S rRNA determined (Eagle
Eye, Stratagene, La Jolla, CA, USA). Total RNA (2mg)
from both SHR and LEW samples was simultaneously
reverse transcribed using a master mix containing
oligo(dT) primer and SuperScript II reverse transcrip-
tase (Invitrogen) in a final volume of 20ml. cDNA was
treated with 2U of RNase H (Invitrogen) at 371C for
20min. Specific primers for the Snca gene and the
control gene cyclophilin A (peptidylprolyl isomerase
A: Ppia) were designed using the Primer3 software
(http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.
cgi). Forward and reverse primers were positioned in
different exons and specificity was confirmed
by a basic local alignment search tool (BLAST)
software-assisted search of a nonredundant nucleo-
tide sequence database for rat sequences (http://
www.ncbi.nlm.nih.gov/BLAST). The primers had
the following sequences: rSNCAF: 50-GAGGGA
GTCGTTCATGGAGT-30, rSNCAR: 50-CATTTGTCAC
TTGCTCTTTGG-30, expected product size=61bp;
rPpiaF: 50-AATGCTGGACCAAACACAAA-30, rPpiaR:
50-CCTTCTTTCACCTTCCCAAA-30, expected product
size: 101. Primers were synthesized by Invitrogen
(Sao Paulo, Brazil), and the correct amplicon sizes
and absence of extra amplification products were
tested in PCR reactions resolved on a 3% agarose gel.
The relative mRNA expression levels were quantified
by an ABI PRISM 7700 Sequence Detection System
(Applied Biosystems, Foster City, CA, USA) and
SYBR green methodology. The optimal concentration
of cDNA and primers as well as the maximum
efficiency of amplification was obtained through a
five-point twofold dilution curve analysis for each
gene. As a result, each PCR reaction contained 12.5ng
of reverse-transcribed RNA, 200nM of each specific
primer, SYBR Green PCR Master Mix (Applied
Biosystems) and RNase-free water to a final volume
of 20ml. cDNA samples from both groups were
processed in the same run in triplicate for each gene,
and samples without cDNA template (NTC) or
primers (NAC) were included as negative controls.
Cycling parameters consisted of 10min at 951C,
followed by 40 cycles at 951C for 15s and 601C for
60s, and a melting step (dissociation curve) was
performed after each run to further confirm the
specificity of the products and the absence of primer
dimers. Real-time data were analyzed using the
Sequence Detector System 1.7 (SDS-Applied Biosys-
tems) and an Excel worksheet. The relative expres-
sion of the Snca gene in the hippocampus and
hypothalamus in the SHR and LEW rats was calcu-
lated according to Vandesompele et al.
36 Briefly, the
arithmetic mean of replicated cycling threshold (Ct)
value of each gene was transformed to a quantity
relative to the sample with the highest expression,
taking into account the amplification efficiency of
each gene. Real-time PCR efficiencies were calculated
using the formula: Efficiency (E)=(10
(1/slope)) 1, from
the slope values given in the SDS and varied from 94
to 100% with a correlation coefficient no lower than
0.93. The raw quantities were subsequently normal-
ized to the reference gene Ppia.
Immunohistochemistry
Undisturbed animals were deeply anesthetized and
perfused through the heart with phosphate-buffered
saline and 4% paraformaldehyde (PFA) in 0.1 M
phosphate buffer (pH 7.4, phosphate buffer, PB).
The brains were removed, postfixed for 4h in PFA
4%, and transferred to a 30% sucrose solution in PB
for 48h to ensure cryoprotection. The brain sections
(30mm) were cut on a sliding microtome adapted for
cryosectioning. The free-floating sections were incu-
bated with a mouse monoclonal antibody directed
against rat a-synuclein (BD Biosciences, San Jose, CA,
USA), which was diluted 1:1000 in PB containing
0.3% Triton X-100 and 5% normal goat serum.
Incubations with the primary antibody were con-
ducted overnight at 241C. The sections were then
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with biotinylated goat anti-mouse serum (Vector,
Burlingame, CA, USA) diluted 1:200 in PB for 2h at
241C. The sections were washed again in PB as above,
and incubated with avidin–biotin–peroxidase com-
plex (ABC Elite, Vector). After washing, the sections
were reacted with 0.05% 3–30-diaminobenzidine and
0.01% hydrogen peroxide in PB. Intensification was
conducted with 0.05% osmium tetroxide in water.
The sections were mounted on gelatinized slides,
dehydrated, cleared and cover-slipped. The material
was analyzed on a light microscope and digital
images were collected. Controls for immunostaining
included omission of the primary antibody, and its
substitution with normal mouse serum, which com-
pletely eliminated staining. It is worth noting that the
antibody used here has been extensively tested and
characterized.
37,38 Immunohistochemical data were
qualitatively analyzed by three independent obser-
vers, and the intensity of labeling was rated as absent,
weak, moderate and intense.
Immunoblotting
Undisturbed rats from both of the strains were killed
by cervical dislocation, and different brain areas were
then collected and homogenized in an extraction
buffer containing 100mM Tris pH 7.4, 10mM EDTA,
2m M phenylmethylsulphonyl fluoride and
0.01mgml
 1 aprotinin. After extraction, the homo-
genates were centrifuged (12000r.p.m., 20min) and
the protein concentration of the supernatant was
determined using a Bradford protein assay (Bio-Rad;
Hercules, CA, USA).
39 Samples containing 100mgo f
protein were loaded onto a 6.5% acrylamide gel and
electrotransferred to nitrocellulose membranes using
a Trans-Blot cell system (Bio-Rad). After the transfer,
the membranes were treated for 4h at room tempera-
ture with a blocking solution containing 5% milk
powder. They were then washed and incubated
overnight at 41C with the same antibody against
a-synuclein (1:2000, BD Biosciences) that was used
for immunohistochemistry, and with a mouse anti-
body against b-tubulin, which was used as an internal
control (Clone DM1A, Sigma, St Louis, MO, USA).
The membranes were then washed and incubated for
2h at room temperature with a peroxidase-conjugated
anti-mouse antibody (Amersham Biosciences, Little
Chalfont, UK), at a dilution of 1:10000. The specifi-
cally bound antibody was visualized using a chemi-
luminescence kit (ECL; Amersham Biosciences). The
blot was densitometrically analyzed using NIH-Scion
Image 4.0.2 (Scion Corporation, Frederick, MD, USA)
and the optical density of the a-synuclein bands were
normalized relative to the optical density of corre-
sponding b-tubulin bands.
High-performance liquid chromatography
Rats were decapitated and their brains were quickly
removed and placed on a cold glass plate 1 day after
the OF test. Hippocampi and hypothalamus were
dissected and frozen at  801C until the time of assay.
The tissues were homogenized in an appropriate
volume of 0.1 M perchloric acid, 0.02% EDTA, 0.02%
sodium metabisulfite and 0.05mM dihydroxybenzyla-
mine as an internal standard, using an ultrasonic
cell disrupter (Cole-Parmer, Vernon Hills, IL, USA).
Samples were then centrifuged (45min, 41C,
14000r.p.m.) and passed through a 0.22mm syringe
filter. We used an HPLC system (Shimadzu Co., Japan,
model LC-10VP) coupled to an electrochemical
detector (Hewlett Packard, Germany, model 1049A)
with a glass-carbon electrode set at 0.65V versus a
solid-state Ag/AgCl reference electrode. Amines and
metabolites were separated by a mC18 column
(250mm length 4.5mm diameter and 5mm particle
size; shim-pack CLC-ODS, Shimadzu) with an iso-
cratic gradient. The mobile phase consisted of 50mM
Na2HPO4, 1.2mM heptane-1-sulfonic acid, 0.2mM
EDTA and methanol (5% v/v in deionized water),
pH 2.6. Peaks were identified by comparison with the
retention time of injected standards. The amounts of
DA, 4-hydroxy-3-methoxyphenylacetic acid (HVA),
and 3,4-dihydroxyphenylacetic acid (DOPAC) in each
sample were estimated by measuring the peak area
relative to the peak areas obtained with known
picogram amounts of the standards. Standards were
purchased from Sigma, and other HPLC-graded
reagents were purchased from Merck (Sao Paulo, SP,
Brazil).
Sequencing
Reverse-transcribed RNAs from eight LEW and seven
SHR rats were amplified using a primer pair designed
based upon the rat a-synuclein mRNA sequence
(GeneBank accession no. NM_019169): (rSncaF)
50-CCCTAGCAGTGAGGCTTATGA-30 and (rSncaR)
50-CACAGCACATCATTCTTCTTAG-30. The size of
the resulting amplicon was 467bp, and covered
previously described 30-untranslated region (30-UTR)
polymorphisms in this gene.
31 The PCR products
were purified using the E.Z.N.A. cycle-pure kit
(Omega Bio-Tek, Doraville, GA, USA) and sequenced
using the BigDye terminator v.3.1 cycle sequencing kit
(Applied Biosystems) in an ABI PRISM 377 DNA
sequencer.
Construction of luciferase reporter plasmids
After performing cDNA sequencing analyses of all the
samples, and identifying a SNP that differed between
the two experimental groups, a new pair of primers
was designed to amplify this specific region:
(rSncaSNP-F) 50-ATTCTAGAGCGTACAAGTGCTCAG
TTCC-30 and (rSncaSNP-R) 50-ATTCTAGATTGAAGC
CACAACAATATCCA-30. The amplified fragments
(207bp) were purified, digested with XbaI, and
ligated into the XbaI-digested pGL-3 promoter vector
between the luciferase gene and the SV40 late poly(A)
signal (Promega, Madison, WI, USA). Competent
Escherichia coli (DH5 alpha; Invitrogen) cells were
transformed with the resulting reporter constructs by
heat shock. Bacterial cells containing plasmid DNA
were selected by using ampicillin in the media.
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reverse primer located in the plasmid vector, RVpri-
mer4 (Promega) and the rSncaSNP-F primer to
identify colonies with the correct fragment orienta-
tion. These plasmids were isolated and sequenced to
confirm that there were no errors in the sequence.
Transient transfection and luciferase activity assay
Rat pheochromocytoma PC12 cells (Ludwig Institute,
SP, Brazil) were cultured in Dulbecco’s modified
Eagle’s medium low glucose (Invitrogen), supplemen-
ted with 10% fetal bovine serum (Invitrogen), anti-
biotics (penicillin and streptomycin) and maintained
at 371C in a humidified 5% CO2 incubator. Cells
(1.0 10
5) were plated into each well of a 12-well
plate 24h before transfection. The pGL-3 luciferase
test plasmids or nonmodified pGL-3 promoter vector
(3.25mg) were transfected in each well by the calcium
phosphate method,
40 and cotransfected using 0.48mg
of Renilla vector (pRL-CMV; Promega) as an internal
control for transfection efficiency. Cells were incu-
bated for 24h, washed and harvested using passive
lysis buffer. Cell extracts were assayed for firefly and
Renilla luciferase activities in a luminometer (Mono
light 2010, Analytical Luminescence Laboratory, San
Diego, CA, USA), using the Dual-Luciferase Reporter
Assay System (Promega). Assays were performed four
times in quadruplicate. The results were calculated as
the mean of luciferase activity from four independent
experiments, normalized for transfection efficiency
and by considering the nonmodified pGL-3 plasmid
to have an activity of 1.
Genotyping an F2 panel for the SNP at þ562 position
After phenotyping in the OF and alcohol drinking
protocol, 73 LEW/SHR F2 male rats were killed and
their livers were removed for DNA extraction. The
genotypes for the SNP at position þ562 (CC, CT or
TT) were determined by PCR followed by restriction
digestion using the following primers: (forward)
50-GATCTGCCCAGGTGTTCTTC-30 and (reverse) 50-
CACACAAGAGCCTGCTACCA-30. In the procedure,
50ng of genomic DNAwas mixed with 5pmol of each
primer and 0.4U of Taq polymerase (Promega) in
Promega colorless buffer, in a 20ml reaction volume.
The PCR cycling conditions were (1) one cycle at
961C for 2min; (2) 38 cycles at 921C for 30s, 611C for
1min and 721C for 31s; (3) one cycle at 721C for
4min. Each PCR (10ml) product was then incubated
with 1U of the MboI restriction enzyme (Invitrogen)
and enzyme-specific buffer at 371C for 3h. MboI
specifically cuts this SNP if the C nucleotide is
present. The digestion products were visualized on
ethidium bromide-stained 2% agarose gels.
Statistical analysis
Data were expressed as mean±s.e.m. Two-tailed
Student’s t-tests were used to compare the behavioral
parameters between SHR and LEW rats in the OF,
EPM, LDB, intake of saccharine, quinine and forced
alcohol tests (because data were normally distributed)
and the HPLC results and immunoblots data. Differ-
ent concentrations of alcohol intake, or preferences
between rat strains were analyzed by a two-way
analysis of variance (ANOVA) for repeated measures
with ‘strain’ as the between-subject factor and ‘con-
centration’ as the within-subject factor. One-way
ANOVA was used for the transfection assays and to
assess the influence of the SNP genotype. Post-hoc
tests were performed using Duncan’s test (GraphPad
Instat, v.3.05 and Statsoft Statistica v.7). Differences
were considered statistically significant if Pp0.05.
Results
Approach of LEW rats toward the aversive areas of the
OF, EPM and LDB apparatuses is reduced
LEW rats showed reduced locomotion in the central
area of the OF when compared to SHR rats (P<0.001).
The total number of quadrants explored by both
groups were not different (P>0.05) (Figure 1a). LEW
rats showed decreased number of entries and percen-
tage of time inside the open arms of the EPM
(P<0.001 and P<0.05, respectively) in relation to
SHRs. However, the number of entries in the closed
arms did not differ between strains (P>0.05) (Figure
1b). The locomotion and percentage of time in the
white compartment of the LDB for LEW rats were also
reduced when compared to SHR rats (P<0.001 for
both; Figure 1c). On the other hand, locomotion in the
dark compartment of the LDB was higher for LEW rats
(P<0.001). In all the three tests, LEW rats avoided the
aversive areas more than SHR rats. These data
confirm that there are behavioral differences between
the strains, and further demonstrate the anxious
profile of LEW rats when compared to SHR rats.
Alcohol preference and consumption in LEW rats is
higher in comparison to SHR rats
Analysis of variance for repeated measures revealed
an interaction between strain and concentration for
alcohol consumption (F(3,57)=10.33; P<0.001); post-
hoc tests revealed that LEW rats consumed more
alcohol at concentrations of 6 and 10% than SHR rats
when alcohol was offered as a free choice with water
(Figure 2a). Furthermore, LEW rats showed a higher
preference for alcohol at all concentrations
(F(1,19)=19.25; P<0.001) (Figure 2b). Consumption of
saccharine and quinine offered as a free choice with
water, as well as the forced consumption of 10%
alcohol were similar between LEW and SHR rats
(P>0.05) (Figures 3a–c).
a-Synuclein gene expression in the hippocampus of
LEW rats is twice the expression in SHR rats
The levels of Snca transcript in the hippocampus
were higher in LEW rats than in SHR rats (P<0.05)
(Figure 4). In the hypothalamus, the levels of Snca
mRNA were similar in both strains (Figure 4). The
levels of the Snca transcript were normalized to the
levels of Ppia mRNA, which did not differ between
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(P>0.05 in all cases).
a-Synuclein protein expression in the hippocampus of
LEW rats is higher than in SHR rats
Densitometric quantification of a-synuclein immuno-
blots showed that there were higher levels of this
protein in the hippocampus of LEW rats when
compared with SHR rats (P<0.05) (Figure 5a). In the
hypothalamus, there were similar levels of a-synu-
clein in both rat strains (Figure 5a). The b-tubulin
immunoblots did not reveal any significant differ-
ences between the LEW and SHR rats in both brain
areas studied. The intensity of a-synuclein labeling as
judged by immunohistochemistry in the hippocam-
pus and hypothalamus was in accordance with the
quantitative assessment of a-synuclein by immuno-
blots (Figure 5b). In addition, the amygdala and
midbrain did not show differences in a-synuclein
protein expression (data not shown).
Dopamine turnover is reduced in the hippocampus
of LEW rats
LEW rats had lower concentrations of DOPAC, a DA
metabolite and a lower DA ratio (DOPAC/DA) in the
hippocampus when compared with SHR rats (P<0.05
and P<0.01, respectively) (Table 1). In the hypotha-
Figure 1 Behavior of spontaneously hypertensive (SHR) and Lewis (LEW) rats in three anxiety tests. (a) Open field: central
(away from the wall) and total locomotion (number of quadrants) during 5min (n=10 per strain); (b) Elevated plus-maze:
number of arm entries (closed and open) and percentage of time spent inside the open arms during 5min (n=8 per strain);
(c) Light/dark box: locomotion (dark and light compartments) and percentage of time spent with all four paws inside the light
compartment during 5min (n=8 per strain). Bars represent means±s.e. *P<0.05 and ***P<0.001; t-test.
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rat strains (P>0.05; Table 1).
30-UTR-a-synuclein cDNA sequencing revealed a single
nucleotide polymorphism that differs between rat strains
Sequencing of 467bp of cDNA derived from the
a-synuclein 30-UTR region revealed a single base pair
change between groups (Table 2). The SNP was a C
(for LEW) to T (for SHR) substitution at position
þ562 (translational start site designated þ1). The
sequence obtained from LEW rats was similar to the
reported rat cDNA sequence for Snca (Rattus norve-
gicus NM_019169—NCBI) at this position. We have
also investigated a previously described 30-UTR SNP
at position þ679 that has been reported to be
responsible for differential expression of this gene;
31
however, there was no alteration in this nucleotide
between the LEW and SHR rat strains. At position
þ439, we found a polymorphism relative to the
published sequence—a C/T substitution; however,
this SNP was identical in both our rat strains (Table
2). This same SNP had also been detected in the
inbred rat strains that differ in their levels of alcohol
consumption and alcohol preference, P (alcohol
preferring) and NP (alcohol nonpreferring), although
this SNP was not functionally relevant to Snca
expression.
31 Some of the other 30-UTR nucleotide
positions that had been reported to differ between
the P and NP
31 strains were also investigated here
(Table 2).
Luciferase activity is higher in PC12 cells transfected
with a construct based upon the LEW 30-UTR sequence
We tested the functionality of the C/T substitution at
position þ562 of the Snca gene sequence by in-vitro
transfection assays. Reporter vector plasmids were
constructed carrying amplicons from either LEW or
SHR sequences in the 30-UTR position (Figure 6). The
constructs and the nonmodified plasmid vector were
transiently transfected in rat PC12 cells and the
luciferase activities were compared. ANOVA revealed
that treatment had a significant effect (F(2,9)=9.07,
P<0.01). The C nucleotide at position þ562 (found
in LEW rats) displayed a luciferase activity that was
91% higher when compared to the T-nucleotide
construct (found in SHR rats) (P<0.01) (Figure 6).
The observed difference in luciferase activity suggests
that the variation in the 30-UTR SNP in LEW rats and
SHR rats may be responsible for the differential
expression of Snca between these two strains.
Figure 2 Alcohol self-administration and preference. (a) Consumption (gkg
 1 per day) and (b) preference (%) of alcohol
offered as a free choice with water at concentrations of 2, 4, 6 and 10% for Spontaneously Hypertensive (SHR) and Lewis
(LEW) rats (n=11 per strain). Values represent means±s.e. **P<0.01; two-way repeated measures analysis of variance
(ANOVA) followed by Duncan’s tests.
Figure 3 Palate preferences of Spontaneously Hyperten-
sive (SHR) and Lewis (LEW) rats. (a) Intake of saccharine
(7.5mM) and (b) quinine (2mM) offered as a free choice with
water and (c) forced intake of alcohol (10%) (n=11 per
strain). Bars represent means±s.e.
a-Synuclein in hippocampus of anxious rats
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differences in OF central locomotion in an F2 panel
A segregating population of F2 male rats, derived
from an intercross between LEW and SHR rats, was
tested in an OF and alcohol protocol, and then was
genotyped for the SNP identified at position þ562.
ANOVA revealed a significant effect of genotype
(F(2,70)=3.38; P<0.05) on central locomotion in the
OF. Post-hoc tests showed that rats carrying two
copies of the SNP allele containing a C nucleotide
displayed higher scores of central locomotion than
rats carrying two copies of the T-containing allele
(P<0.01). The central quadrants crossed for the three
possible genotypes were 18.9±1.9 for CC (n=13);
15.9±1.1 for CT (n=36) and 12.9±1.4 for TT (n=24).
No effects of genotype were found for alcohol
preference or consumption (P>0.05; data not shown).
Discussion
Rats from the inbred LEW strain displayed increased
anxiety-like behavior when compared to the inbred
SHR strain, thus confirming previous findings. The
anxious-like profile of LEW rats was demonstrated in
the present study by their reduced approach toward
aversive areas in three different anxiety tests. LEW
rats explored the central area of the OF, the open arms
of the EPM and the light compartment of the LDB less
than the SHR strain. This phenotypic difference has
been shown to be robust and reliably observed, even
when the strains are obtained from different sources
and tested in different laboratories,
12,13,41,42 which
makes the LEW and SHR rats an important tool in the
genetic study of emotionality.
Epidemiological evidence suggests that stressful life
events and anxious-like personality traits may increase
vulnerability to alcoholism.
43,44 The tension-reduction
Figure 4 Levels of a-synuclein mRNA in the hippocampus
and hypothalamus of Spontaneously Hypertensive (SHR)
and Lewis (LEW) rats (n=7–8 per strain). Bars represent
means±s.e. *P<0.05; t-test.
Figure 5 a-Synuclein protein expression assessed by (a)
immunoblots of hippocampus and hypothalamus of Spon-
taneously Hypertensive (SHR) and Lewis (LEW) rats. (n=
7–8 per strain). Bars represent means±s.e. *P<0.05; t-test.
(b) immunohistochemistry of the hippocampus of both
strains (scale bar: 50mm).
Table 1 Concentration of dopamine and its metabolites
DOPAC and HVA, in the hippocampus and hypothalamus of
LEW and SHR rats (ngmg
 1 protein)
Brain area SHR (n=7) LEW (n=8)
Hippocampus
DA 0.50±0.15 0.46±0.08
DOPAC 0.85±0.14 0.42±0.05*
HVA 2.10±0.47 1.64±0.25
DOPAC/DA 2.44±0.39 1.07±0.16**
Hypothalamus
DA 8.46±0.70 8.99±1.04
DOPAC 1.13±0.20 1.41±0.23
HVA 3.73±0.57 3.75±0.64
DOPAC/DA 0.13±0.02 0.15±0.01
Abbreviations: DA, dopamine; DOPAC, 3,4-dihydroxyphe-
nylacetic acid; HVA, 4-hydroxy-3-methoxyphenylacetic
acid; LEW, Lewis; SHR, Spontaneously Hypertensive Rats.
*P<0.5 and **P<0.01; t-test.
Table 2 Nucleotide at the 30-UTR region of a-synuclein
cDNA at designated positions in different rat strains. P, NP
and NM_019169 (sequence from NCBI)
Position
Rats þ439 þ562 þ679 þ717 þ735 þ807
PC C G T T G
NP T C A T T G
NM_019169 C C A T T A
LEW T C A T T A
SHR T T A T T A
Abbreviations: P, inbred alcohol preferring; NP, inbred
alcohol nonpreferring; ; LEW, Lewis; SHR, Spontaneously
Hypertensive.
a-Synuclein in hippocampus of anxious rats
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45 predicts
that individuals who are naturally anxious and more
sensitive to the anxiolytic effects of alcohol show a
higher tendency for alcohol abuse.
46 Furthermore,
Pandey
47 proposed that cAMP response element-
binding protein (CREB) regulates the expression of
genes affecting behaviors associated with anxiety and
alcohol consumption. Together, these studies suggest
that common molecular mechanisms may underlie
anxiety-related disorders and alcohol addiction. One of
the objectives of the present study was to investigate
this putative association in a genetic animal model.
Under a protocol of alcohol consummatory behavior,
the anxious LEW rats consumed higher quantities of
alcohol (for concentrations of 6 and 10%) under free
choice, and had a higher alcohol preference (regardless
of concentration) when compared with SHR rats.
However, the intake of sweet or bitter substances, as
well as 10% alcohol offered alone, was similar
between the two strains, suggesting that the differences
observed in alcohol consumption were not due to
differences in taste or smell preference. Since previous
studies used the same strains, but used different
alcohol drinking protocols and housing conditions,
and reported different findings,
20,48 we replicated our
experiment under the same conditions used here. The
results confirmed that LEW male rats tend to drink
more alcohol than their SHR counterparts under our
experimental conditions (data not shown).
Many genes are believed to contribute to anxiety-
related traits and to other complex behaviors, such as
alcohol consumption. A genomic region on rat
chromosome 4 (Ofil1) has been shown to contribute
to inter-individual differences in OF central locomo-
tion within an F2 population of rats derived from the
LEW and SHR strains.
14 Interestingly, the chromo-
some region neighboring this QTL also affects alcohol
consumption. Studies using lines of rats selectively
bred for high and low alcohol preference (P and NP
rats) have reported that there is a major locus on
chromosome 4 linked to alcohol consumption.
49,50
Another whole-genome screen performed in F2
animals derived from high-ethanol preferring and
Wistar–Kyoto rats, led to the identification of another
QTL (Coet5) on chromosome 4, also in close proxi-
mity to Ofil1 that influenced alcohol intake.
51 Follow-
up studies showed that this locus also affected central
locomotion in the OF,
52 and that P and NP rats also
differ in tests of emotionality.
53 Together, these results
suggest that one or more genes located on rat
chromosome 4 are partially responsible for the inter-
individual variation observed in anxiety- and alcohol-
related behaviors among laboratory rats.
A strong candidate gene that maps to this genome
region is Snca, which encodes a-synuclein, a 140
amino-acid protein. Due to its position and function,
this gene might explain the effect of the QTL for
alcohol intake found in P and NP rats.
31,49,50 a-
Synuclein mRNA and protein are highly expressed
in the hippocampus,
54–58 where they are elevated in
the selected inbred P rats when compared with the
NP strain.
31 A role for hippocampal formation in
anxiety has been demonstrated and suggested by
many studies.
59–62 Accordingly, in the present study,
a-synuclein mRNA levels were twice as high in the
hippocampus of the anxious LEW rats when com-
pared to SHR rats. This increase in gene expression
was accompanied by a corresponding increase in a-
synuclein protein expression, which showed an
elevation of approximately 50% in the hippocampus
of LEW rats when compared to SHR rats. a-Synuclein
protein expression was also higher in the striatum of
the anxious LEW animals (B44% higher compared
with SHR, data not shown). Neither gene nor protein
expression in the hypothalamus differed between
strains. This site-specific effect has previously been
observed between P and NP rats.
31
The physiological role of a-synuclein remains
unclear, despite intense research into the role of a-
synuclein in neurodegenerative diseases, especially
Parkinson’s disease, where this protein is a constant
component of Lewy bodies.
63 Genetic variability in
the a-synuclein gene is a risk factor for the develop-
ment of Parkinson’s disease.
64–68 Null mutant mice
lacking a-synuclein exhibit a lower locomotor
response to amphetamine,
69 whereas transgenic
animals overexpressing a-synuclein display signs of
motor impairment associated with a decrease in
tyrosine hydroxylase levels.
70 These data suggest that
a-synuclein downregulates dopaminergic neurotrans-
mission, possibly by inhibiting tyrosine hydroxylase
activity.
22 In the present study, DA and its metabolites
also appear to be disturbed in the hippocampus of
Figure 6 Functionality of the C/T substitution at position
þ562 of the 30-untranslated region (30-UTR) of the a-
synuclein gene. Luciferase activity of PC12 cells transfected
with (a) pGL-3 promoter vector, or with plasmids carrying
(b) Spontaneously Hypertensive (SHR) or (c) Lewis (LEW)
sequences in the 30-UTR. The bars represent means±s.e. of
four independent transfection experiments performed in
quadruplicate. **P<0.01; analysis of variance (ANOVA)
followed by Duncan’s test.
a-Synuclein in hippocampus of anxious rats
S Chiavegatto et al
9
Molecular Psychiatryanxious LEW rats, when compared to SHR animals.
The ratio between DA metabolites and DA, which
reflects DA turnover, is B2.3 times lower in the
hippocampus and is significantly reduced in the
striatum of LEW rats. However, this is not the case in
the hypothalamus, which is an area where the a-
synuclein levels and DA turnover are similar between
strains. Therefore, our data strengthen the hypothe-
tical role of a-synuclein in the regulation of synaptic
DA homeostasis.
71
A search on WebQTL (www.genenetwork.org) re-
vealed significant correlations (P<0.05) between the
expression of a-synuclein mRNA in the hippocampus
of BXD recombinant inbred mouse lines and several
phenotypes that are potentially relevant to the present
study, such as OF activity in response to alcohol
(r= 0.45); exploratory activity in a holeboard in
response to cocaine (r= 0.61); % time in the light
compartment of the LDB (r= 0.50) and DA transpor-
ter expression in the nucleus accumbens (r= 0.55).
These results reinforce the possible role of the Snca
gene in modulating anxiety- and alcohol-related
behaviors through dopaminergic mechanisms.
The possibility that sequence differences in Snca
gene might account for the differential expression
observed between LEW and SHR rats was investigated
in the 30-UTR of Snca. Although regulation of rat Snca
gene expression is complex, it has recently been shown
that polymorphisms in the Snca promoter region found
between P and NP rats were not biologically relevant in
reporter assays. However, a SNP in the 30-UTR region
altered the stability of the Snca mRNA, which is
consistent with the strain differences in gene expres-
sion.
72 The change in bases G/A at position þ679 for P
and NP rats, respectively, was not found in our LEW/
SHR rats. In this position, both strains have the A
nucleotide. Interestingly, we found a single novel SNP
in the 30-UTR sequence, which is a C/T substitution at
þ562 for LEW and SHR, respectively, which altered
the efficiency of expression of a reporter gene transi-
ently transfected into rat PC12 cells. The construct
with a C at position þ562 (as in LEW rats) almost
doubled (an increase of 91%) the in-vitro expression,
consistent with the higher a-synuclein gene and
protein expression in the hippocampus of anxious
LEW rats. It is possible that the 30-UTR SNP found in
our animals, 117 bases away from the SNP found
between P and NP rats, may similarly alter the half-life
of Snca transcripts, protecting the message from
degradation.
72 How the change in expression occurs
in specific brain areas and the nature of the molecular
components that modulate the influence of this SNP
upon gene expression in a site-dependent manner are
interesting issues that remain to be investigated.
As already mentioned, in humans, some highly
anxious individuals show higher predisposition to
develop alcoholism.
73–77 The behavioral profile of
LEW and SHR rats found in the present study might
be seen as an experimental support to this comorbid-
ity. However, our working hypothesis is that there is
only a partial genetic overlap between alcohol drink-
ing and emotionality (that is, some predisposing
genes are common and some are not), and these
behaviors are highly dependent on environmental
factors, which would explain why these traits appear
associated in some cases but not in others. Moreover,
LEW and SHR rats, unlike P and NP rats, have never
been selectively bred for any anxiety- or alcohol-
related phenotype. All of the behavioral differences
described herein are the product of independent
evolutionary histories between these two strains,
and this is analogous to different human populations.
In order to further investigate whether the
a-synuclein gene SNP identified in the present study
is a good candidate that can explain a common
vulnerability to both anxiety- and alcohol-related
behaviors, a segregating population of F2 rats, derived
from the intercross between LEW and SHR strains,
was tested in an OF and an alcohol drinking protocol,
before being genotyped. Our results showed that the
Snca allele containing a C nucleotide at þ562 was
associated, in a dose-dependent manner, with higher
ambulation in the center of the OF. The direction of
this association (that is, LEW-derived alleles related
to higher rather than lower central locomotion) is
consistent with previous findings
14,19,20 regarding the
Ofil1 QTL and with the polygenic nature of complex
phenotypes, which very often unveil QTLs that act in
opposing directions.
78–82 However, it is important to
point out that although this association strategy is
extremely useful for the corroboration of potential
cause–consequence relationships, it cannot provide a
final answer regarding the functional link between
gene and phenotype, as the influence of other poly-
morphic sequences mapping to the same chromosome
region, and physically linked to the SNP of interest,
cannot be disregarded. Finally, the lack of association
between the present SNP and alcohol consumption in
the F2 rats suggests that although this polymorphism
stood out as a good candidate for emotionality, it
cannot be confirmed as a candidate polymorphism
that has a simultaneous action on both anxiety and
alcohol intake in the current animal model.
In summary, we report increased a-synuclein
mRNA and protein expression and decreased dopa-
minergic activity in the hippocampus of anxious LEW
rats when compared to less-anxious SHR rats. These
differences are not observed in the hypothalamus.
The a-synuclein gene maps to an area of rat chromo-
some 4 that harbors several QTLs previously asso-
ciated with anxiety- and alcohol-related behaviors. In
addition, we discovered a novel SNP at position
þ562 in the 30-UTR region of the a-synuclein gene
between LEW and SHR rat strains, which have been
previously used in genetic studies of anxiety. This
SNP can alter the expression of a reporter gene in in-
vitro assays in accordance with in-vivo findings,
suggesting that the 30-UTR SNP may be responsible
for the alteration in a-synuclein gene expression
between the strains. These results are consistent with
the idea of a novel role for a-synuclein in modulating
anxiety-like behavior in rats, possibly through dopa-
a-Synuclein in hippocampus of anxious rats
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Molecular Psychiatryminergic mechanisms, and highlight the possibility
that polymorphisms in the a-synuclein gene may be
associated with a higher vulnerability to anxiety-
related disorders in humans.
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